Wells Fargo
TMDX icon

Wells Fargo’s Transmedics TMDX Stock Holding History

Wells Fargo’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,000
Closed -$471K – 7193
2024
Q3 		$471K Buy
+3,000
New +$462K ﹤0.01% 4032
2023
Q2 		– Sell
-135,100
Closed -$10.2M – 7699
2023
Q1 		$10.2M Buy
+135,100
New +$9.34M ﹤0.01% 1573
2022
Q4 		– Sell
-27,900
Closed -$1.17M – 7727
2022
Q3 		$1.17M Buy
+27,900
New +$1.21M ﹤0.01% 3136

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Wells Fargo's TMDX Position: Q2 2026 in Review

Wells Fargo reduced its Transmedics (TMDX) stake by 5% in Q2 2026, selling an estimated $1.15M and leaving 260,218 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Wells Fargo first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $31.5M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Wells Fargo held 260,218 shares of Transmedics worth $17.3M as of Q2 2026.
  • Wells Fargo sold 13,583 Transmedics shares in Q2 2026, an estimated $1.15M.
  • Transmedics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1753 holding.
  • Wells Fargo first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Wells Fargo's Transmedics position peaked at $31.5M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.